Global (Us, Eu,China) Transcervical Female Sterilization Market 2020 Research Forecast 2026

Published On: Dec 2019

Format: PDF

Publisher: QY Research

Pages: 110

Report ID: 84316

Transcervical tubal sterilization. Transcervical sterilization or tubal occlusion is a procedure that offers permanent birth control for women. It is a highly effective, minimally invasive alternative to surgical tubal ligation.
In 2019, the market size of Transcervical Female Sterilization is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Transcervical Female Sterilization.

This report studies the global market size of Transcervical Female Sterilization, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Transcervical Female Sterilization production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Ethicon
Medtronic
Karl Storz
Olympus
Applied Medical
Richard Wolf
Bayer AG
Stryker
B. Braun Aesculap
ERBE
LiNA Medical
ConMed
Microline Surgical
Apollo Endosurgery

Market Segment by Product Type
Tubal Ligation
Transcervical Implant

Market Segment by Application
Hospital
Clinic

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Transcervical Female Sterilization status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Transcervical Female Sterilization manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Transcervical Female Sterilization are as follows:
History Year: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Year 2020 to 2026

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Transcervical Female Sterilization Market Size Growth Rate by Type (2020-2026)
1.3.2 Tubal Ligation
1.3.3 Transcervical Implant
1.4 Market Segment by Application
1.4.1 Global Transcervical Female Sterilization Market Share by Application (2020-2026)
1.4.2 Hospital
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Transcervical Female Sterilization Production Value 2015-2026
2.1.2 Global Transcervical Female Sterilization Production 2015-2026
2.1.3 Global Transcervical Female Sterilization Capacity 2015-2026
2.1.4 Global Transcervical Female Sterilization Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2026
2.2.1 Global Transcervical Female Sterilization Market Size CAGR of Key Regions
2.2.2 Global Transcervical Female Sterilization Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Transcervical Female Sterilization Capacity by Manufacturers
3.1.2 Global Transcervical Female Sterilization Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Transcervical Female Sterilization Revenue by Manufacturers (2015-2020)
3.2.2 Transcervical Female Sterilization Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transcervical Female Sterilization Market Concentration Ratio (CR5 and HHI)
3.3 Transcervical Female Sterilization Price by Manufacturers
3.4 Key Manufacturers Transcervical Female Sterilization Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Transcervical Female Sterilization Market
3.6 Key Manufacturers Transcervical Female Sterilization Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Tubal Ligation Production and Production Value (2015-2020)
4.1.2 Transcervical Implant Production and Production Value (2015-2020)
4.2 Global Transcervical Female Sterilization Production Market Share by Type
4.3 Global Transcervical Female Sterilization Production Value Market Share by Type
4.4 Transcervical Female Sterilization Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Transcervical Female Sterilization Consumption by Application

6 Production by Regions
6.1 Global Transcervical Female Sterilization Production (History Data) by Regions 2015-2020
6.2 Global Transcervical Female Sterilization Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Transcervical Female Sterilization Production Growth Rate 2015-2020
6.3.2 United States Transcervical Female Sterilization Production Value Growth Rate 2015-2020
6.3.3 Key Players in United States
6.3.4 United States Transcervical Female Sterilization Import & Export
6.4 European Union
6.4.1 European Union Transcervical Female Sterilization Production Growth Rate 2015-2020
6.4.2 European Union Transcervical Female Sterilization Production Value Growth Rate 2015-2020
6.4.3 Key Players in European Union
6.4.4 European Union Transcervical Female Sterilization Import & Export
6.5 China
6.5.1 China Transcervical Female Sterilization Production Growth Rate 2015-2020
6.5.2 China Transcervical Female Sterilization Production Value Growth Rate 2015-2020
6.5.3 Key Players in China
6.5.4 China Transcervical Female Sterilization Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia

7 Transcervical Female Sterilization Consumption by Regions
7.1 Global Transcervical Female Sterilization Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Transcervical Female Sterilization Consumption by Type
7.2.2 United States Transcervical Female Sterilization Consumption by Application
7.3 European Union
7.3.1 European Union Transcervical Female Sterilization Consumption by Type
7.3.2 European Union Transcervical Female Sterilization Consumption by Application
7.4 China
7.4.1 China Transcervical Female Sterilization Consumption by Type
7.4.2 China Transcervical Female Sterilization Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Transcervical Female Sterilization Consumption by Type
7.5.2 Rest of World Transcervical Female Sterilization Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia

8 Company Profiles
8.1 Ethicon
8.1.1 Ethicon Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Transcervical Female Sterilization
8.1.4 Transcervical Female Sterilization Product Introduction
8.1.5 Ethicon Recent Development
8.2 Medtronic
8.2.1 Medtronic Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Transcervical Female Sterilization
8.2.4 Transcervical Female Sterilization Product Introduction
8.2.5 Medtronic Recent Development
8.3 Karl Storz
8.3.1 Karl Storz Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Transcervical Female Sterilization
8.3.4 Transcervical Female Sterilization Product Introduction
8.3.5 Karl Storz Recent Development
8.4 Olympus
8.4.1 Olympus Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Transcervical Female Sterilization
8.4.4 Transcervical Female Sterilization Product Introduction
8.4.5 Olympus Recent Development
8.5 Applied Medical
8.5.1 Applied Medical Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Transcervical Female Sterilization
8.5.4 Transcervical Female Sterilization Product Introduction
8.5.5 Applied Medical Recent Development
8.6 Richard Wolf
8.6.1 Richard Wolf Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Transcervical Female Sterilization
8.6.4 Transcervical Female Sterilization Product Introduction
8.6.5 Richard Wolf Recent Development
8.7 Bayer AG
8.7.1 Bayer AG Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Transcervical Female Sterilization
8.7.4 Transcervical Female Sterilization Product Introduction
8.7.5 Bayer AG Recent Development
8.8 Stryker
8.8.1 Stryker Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Transcervical Female Sterilization
8.8.4 Transcervical Female Sterilization Product Introduction
8.8.5 Stryker Recent Development
8.9 B. Braun Aesculap
8.9.1 B. Braun Aesculap Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Transcervical Female Sterilization
8.9.4 Transcervical Female Sterilization Product Introduction
8.9.5 B. Braun Aesculap Recent Development
8.10 ERBE
8.10.1 ERBE Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Transcervical Female Sterilization
8.10.4 Transcervical Female Sterilization Product Introduction
8.10.5 ERBE Recent Development
8.11 LiNA Medical
8.12 ConMed
8.13 Microline Surgical
8.14 Apollo Endosurgery

9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Transcervical Female Sterilization Capacity, Production Forecast 2020-2026
9.1.2 Global Transcervical Female Sterilization Production Value Forecast 2020-2026
9.2 Market Forecast by Regions
9.2.1 Global Transcervical Female Sterilization Production and Value Forecast by Regions 2020-2026
9.2.2 Global Transcervical Female Sterilization Consumption Forecast by Regions 2020-2026
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Transcervical Female Sterilization Production Forecast by Type
9.7.2 Global Transcervical Female Sterilization Production Value Forecast by Type
9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Transcervical Female Sterilization Sales Channels
10.2.2 Transcervical Female Sterilization Distributors
10.3 Transcervical Female Sterilization Customers

11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer